APC Recommendations:

 

Insulin Lyumjev® (Lilly) :-

 

This is a new analogue insulin formulation of insulin lispro. It is formulated to be faster acting.

 

JPC Recommendation (based on the recommendations from the Diabetic Sub group):-

 

• The JPC supported the use of Insulin Lyumjev® as a treatment option for the same group of patients as Fiasp® with the exception that Insulin Lyumjev® is for adult patients only.

 

Click here to see the Fiasp® criteria